Trademark applications and grants for Genitrix L L C. Genitrix L L C has 2 trademark applications. The latest application filed is for "GENITRIX"
Patent Application | Date |
---|---|
CD40 ligand-enhanced cells and methods of modulating an immune response to an antigen 20100297154 - 12/151908 Segal; Andrew H. | 2010-11-25 |
Lectin compositions and methods for modulating an immune response to an antigen 20100292453 - 12/655083 Segal; Andrew H. ;   et al. | 2010-11-18 |
Nucleic acid compositions and methods of introducing nucleic acids into cells 20090191170 - 12/069441 Segal; Andrew H. ;   et al. | 2009-07-30 |
Cytokine-coated cells and methods of modulating an immune response to an antigen 20070269455 - 11/633882 Segal; Andrew H. | 2007-11-22 |
Nucleic acid compositions and methods of introducing nucleic acids into cells 20050153312 - 10/960128 Segal, Andrew H. ;   et al. | 2005-07-14 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "GENITRIX" 75708343 |
GENITRIX 1999-05-17 |
![]() "GENITRIX" 75440949 |
GENITRIX 1998-02-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.